Merger and buyout activity is likely to heat up in the healthcare sector in 2010 as the debate over a national health overhaul winds down, the Wall Street Journal
reports. Biopharma is expected to remain active as pharmaceutical companies continue to bolster weakening pipelines, while stronger credit markets could bring more leveraged buyouts that could bode well for more deals in medical technology and healthcare services, reports the Journal
. In addition, health insurers that have maintained their cash may seek opportunities once they have some clarity on the revised U.S. healthcare regulations.